QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)
Clinical trial NCT07441317 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07441317
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-01
- Primary completion
- 2027-12-01
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.